Compare NRT & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRT | MYO |
|---|---|---|
| Founded | 1975 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Industrial Specialties |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.0M | 68.9M |
| IPO Year | 1995 | 2017 |
| Metric | NRT | MYO |
|---|---|---|
| Price | $9.09 | $1.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 39.9K | ★ 772.3K |
| Earning Date | 05-29-2026 | 05-08-2026 |
| Dividend Yield | ★ 10.18% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | N/A | ★ $1,000,000,000.00 |
| Revenue This Year | N/A | $9.10 |
| Revenue Next Year | N/A | $13.59 |
| P/E Ratio | $21.21 | ★ N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $4.99 | $0.61 |
| 52 Week High | $10.49 | $1.89 |
| Indicator | NRT | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 60.83 | 49.51 |
| Support Level | $8.48 | $1.36 |
| Resistance Level | $9.52 | $1.89 |
| Average True Range (ATR) | 0.25 | 0.17 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 85.54 | 14.02 |
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.